ADSB-FUB-187 100g

$450,00 $427,50



ADSB-FUB-187 It’s cannabinoid and analog of ADB-Fubinaca IUPAC name: 7-chloro-N-[(2S)-1-[2-(cyclopropylsulfonylamino)ethylamino]-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide CAS number: 1185283-97-9

Formula: C26H31ClFN5O4S

Purity: 99,8% min

Appearance: white powder/yellow powder.

ADSB-FUB-187 is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB1 receptor with a binding affinity of Ki = 0.09 nM and an EC50 of 1.09 nM. It was originally developed by Pfizer in 2009, being example 187 from patent WO 2009/106982. While it is the most tightly binding compound from this patent in terms of Ki, it is not the most potent compound at producing a CB1 mediated pharmacological effect, with at least 17 other compounds from the patent having lower EC50 values

The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.

1 review for ADSB-FUB-187 100g

  1. Shults

Add a review

Your email address will not be published. Required fields are marked *